Why is Brooks Lab. falling/rising?

As of 18-Jul, Brooks Laboratories Ltd is experiencing a decline in its stock price, currently at 156.60, which represents a decrease of 3.15 or 1.97%. Today's price summary indicates that the stock has underperformed its sector by 1.42% and has seen a trend reversal after seven consecutive days of gains. Despite this drop, the stock has shown strong performance over the past week and month, with returns of 5.78% and 23.31%, respectively. However, the company faces challenges, including weak long-term fundamental strength, as evidenced by an average Return on Equity (ROE) of 0% and a negative EBIT to Interest ratio. While the stock has generated an impressive 85.22% return over the past year, its profits have only increased by 49.2%, indicating potential valuation concerns.
In the broader market context, Brooks Laboratories has outperformed the Sensex in both the short-term and long-term, with a 1-year return significantly higher than the benchmark's 0.51%. However, the stock's recent volatility, with an intraday volatility of 220.84%, suggests that investor sentiment may be fluctuating. The company's liquidity appears adequate for trading, but the weak growth in net sales over the past five years and the high price-to-book value ratio may be contributing to the current price decline. Overall, while the stock has shown strong historical performance, the combination of recent underperformance and fundamental weaknesses may be influencing its current downward movement.